Your browser doesn't support javascript.
loading
Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
Dufresne, Sébastien S; Boulanger-Piette, Antoine; Bossé, Sabrina; Argaw, Anteneh; Hamoudi, Dounia; Marcadet, Laetitia; Gamu, Daniel; Fajardo, Val A; Yagita, Hideo; Penninger, Josef M; Russell Tupling, A; Frenette, Jérôme.
Affiliation
  • Dufresne SS; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada.
  • Boulanger-Piette A; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada.
  • Bossé S; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada.
  • Argaw A; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada.
  • Hamoudi D; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada.
  • Marcadet L; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada.
  • Gamu D; Department of Kinesiology, University of Waterloo, Waterloo, ON, N2L 3G1, Canada.
  • Fajardo VA; Department of Kinesiology, University of Waterloo, Waterloo, ON, N2L 3G1, Canada.
  • Yagita H; Department of Immunology, Juntendo University, School of Medicine, Tokyo, Japan.
  • Penninger JM; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030, Vienna, Austria.
  • Russell Tupling A; Department of Kinesiology, University of Waterloo, Waterloo, ON, N2L 3G1, Canada.
  • Frenette J; Centre Hospitalier Universitaire de Québec-Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CRCHUL), Université Laval, 2705 boulevard Laurier, RC-9500, Quebec City, QC, G1V 4G2, Canada. jerome.frenette@crchul.ulaval.ca.
Acta Neuropathol Commun ; 6(1): 31, 2018 04 24.
Article in En | MEDLINE | ID: mdl-29699580
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscle, Skeletal / Receptor Activator of Nuclear Factor-kappa B / Osteoprotegerin / Muscular Dystrophies Type of study: Prognostic_studies Limits: Animals Language: En Journal: Acta Neuropathol Commun Year: 2018 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscle, Skeletal / Receptor Activator of Nuclear Factor-kappa B / Osteoprotegerin / Muscular Dystrophies Type of study: Prognostic_studies Limits: Animals Language: En Journal: Acta Neuropathol Commun Year: 2018 Document type: Article Affiliation country: Canada